These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7939508

  • 41. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig.
    Nilsson L, Storm KE, Thelin S, Bagge L, Hultman J, Thorelius J, Nilsson U.
    Artif Organs; 1990 Feb; 14(1):46-8. PubMed ID: 2302076
    [Abstract] [Full Text] [Related]

  • 42. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [Abstract] [Full Text] [Related]

  • 43. Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery.
    Belboul A, al-Khaja N.
    Perfusion; 1997 Nov; 12(6):385-91. PubMed ID: 9413851
    [Abstract] [Full Text] [Related]

  • 44. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
    Moen O, Fosse E, Brockmeier V, Andersson C, Mollnes TE, Høgåsen K, Venge P.
    Ann Thorac Surg; 1995 Nov; 60(5):1317-23. PubMed ID: 8526620
    [Abstract] [Full Text] [Related]

  • 45. Evidence for complement activation by protamine-heparin interaction after cardiopulmonary bypass.
    Cavarocchi NC, Schaff HV, Orszulak TA, Homburger HA, Schnell WA, Pluth JR.
    Surgery; 1985 Sep; 98(3):525-31. PubMed ID: 3875906
    [Abstract] [Full Text] [Related]

  • 46. Active or passive bio-coating: does it matters in extracorporeal circulation?
    Jacobs S, De Somer F, Vandenplas G, Van Belleghem Y, Taeymans Y, Van Nooten G.
    Perfusion; 2011 Nov; 26(6):496-502. PubMed ID: 21719530
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass.
    Lundblad R, Moen O, Fosse E.
    Ann Thorac Surg; 1997 May; 63(5):1361-7. PubMed ID: 9146328
    [Abstract] [Full Text] [Related]

  • 56. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
    Shimamoto A, Kanemitsu S, Fujinaga K, Takao M, Onoda K, Shimono T, Tanaka K, Shimpo H, Yada I.
    Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
    van den Goor J, Nieuwland R, van den Brink A, van Oeveren W, Rutten P, Tijssen J, Eijsman L.
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
    [Abstract] [Full Text] [Related]

  • 59. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
    Noguchi M, Eishi K, Tada S, Yamachika S, Hazama S, Izumi K, Tanigawa K.
    Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.